Fulcrum Therapeutics' Series A Round

Fulcrum Therapeutics raised a round of funding on July 19, 2016. Investors include Third Rock Ventures.

Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients and their families by transforming gene regulation in disease. Fulcrum's therapies are base…

Articles about Fulcrum Therapeutics' Series A Round: